DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,311,000 | +26.9% | 3,983 | +17.5% | 0.09% | +6.2% |
| Q3 2021 | $1,033,000 | +40.5% | 3,390 | +23.8% | 0.08% | +37.3% |
| Q2 2021 | $735,000 | +24.4% | 2,739 | +4.4% | 0.06% | +13.5% |
| Q1 2021 | $591,000 | -0.8% | 2,623 | -2.2% | 0.05% | -8.8% |
| Q4 2020 | $596,000 | +18.3% | 2,683 | +14.8% | 0.06% | +5.6% |
| Q3 2020 | $504,000 | +91.6% | 2,337 | +57.3% | 0.05% | +74.2% |
| Q2 2020 | $263,000 | +14.3% | 1,486 | -10.4% | 0.03% | +3.3% |
| Q1 2020 | $230,000 | -39.2% | 1,659 | -32.6% | 0.03% | -23.1% |
| Q4 2019 | $378,000 | +38.5% | 2,460 | +30.1% | 0.04% | +30.0% |
| Q3 2019 | $273,000 | +5.8% | 1,891 | +5.0% | 0.03% | +7.1% |
| Q2 2019 | $258,000 | -30.5% | 1,801 | -35.9% | 0.03% | -70.2% |
| Q1 2019 | $371,000 | +127.6% | 2,808 | +77.5% | 0.09% | +176.5% |
| Q4 2018 | $163,000 | -1.8% | 1,582 | +3.4% | 0.03% | -55.8% |
| Q3 2018 | $166,000 | -31.1% | 1,530 | -44.9% | 0.08% | +14.9% |
| Q3 2017 | $241,000 | -99.9% | 2,775 | -12.9% | 0.07% | +1.5% |
| Q2 2017 | $269,000,000 | -0.4% | 3,186 | -1.5% | 0.07% | -12.0% |
| Q1 2017 | $270,000,000 | -18.9% | 3,236 | -24.3% | 0.08% | +29.3% |
| Q4 2016 | $333,000,000 | +141602.1% | 4,274 | +42.8% | 0.06% | +38.1% |
| Q3 2016 | $235,000 | -6.0% | 2,994 | +20.6% | 0.04% | -46.8% |
| Q2 2016 | $250,000 | +30.9% | 2,482 | +23.2% | 0.08% | +17.9% |
| Q1 2016 | $191,000 | +28.2% | 2,015 | +25.5% | 0.07% | +19.6% |
| Q4 2015 | $149,000 | +13.7% | 1,605 | +4.2% | 0.06% | +19.1% |
| Q3 2015 | $131,000 | +151.9% | 1,540 | +149.2% | 0.05% | +161.1% |
| Q2 2015 | $52,000 | +36.8% | 618 | +37.3% | 0.02% | +50.0% |
| Q1 2015 | $38,000 | -2.6% | 450 | 0.0% | 0.01% | -7.7% |
| Q4 2014 | $39,000 | +14.7% | 450 | -0.2% | 0.01% | +85.7% |
| Q3 2014 | $34,000 | 0.0% | 451 | 0.0% | 0.01% | -61.1% |
| Q2 2014 | $34,000 | – | 451 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |